Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2016)
Achieve Life Sciences (ACHV) posted Receivables - Other of $32000.0 for Q4 2016, down 11.11% on a QoQ basis from $36000.0 in Q3 2016, and down 71.17% year-over-year from $111000.0 in Q1 2016.
Achieve Life Sciences (ACHV) Receivables - Other (2011 - 2016) Analysis & Trends
Achieve Life Sciences' Receivables - Other history runs 6 years deep, the most recent figure standing at $32000.0 for Q4 2016.
- Quarterly Receivables - Other fell 71.17% year-over-year to $32000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $32000.0 (down 71.17% YoY) and the FY2016 annual result came in at $32000.0, down 71.17% from the prior year.
- Receivables - Other was $32000.0 for Q4 2016 at Achieve Life Sciences, down from $36000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $327000.0 in Q4 2012 and bottomed at $19000.0 in Q3 2014.
- A 5-year average of $139562.5 and a median of $93500.0 in 2015 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2014 — Receivables - Other tumbled 93.56% — and 2015, when it surged 152.63%.
- Achieve Life Sciences' Receivables - Other stood at $327000.0 in 2012, then slumped by 33.33% to $218000.0 in 2013, then slumped by 48.17% to $113000.0 in 2014, then dropped by 1.77% to $111000.0 in 2015, then sank by 71.17% to $32000.0 in 2016.
- Business Quant data shows ACHV's Receivables - Other at $32000.0 in Q4 2016, $36000.0 in Q3 2016, and $47000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 32,000.00 |
| Dec 31, 2016 | 32,000.00 |
| Sep 30, 2016 | 36,000.00 |
| Sep 30, 2016 | 36,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Mar 31, 2016 | 53,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Dec 31, 2015 | 111,000.00 |
| Sep 30, 2015 | 48,000.00 |
| Sep 30, 2015 | 48,000.00 |
| Jun 30, 2015 | 76,000.00 |
| Jun 30, 2015 | 76,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Mar 31, 2015 | 71,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Dec 31, 2014 | 113,000.00 |
| Sep 30, 2014 | 19,000.00 |
| Sep 30, 2014 | 19,000.00 |